Stopping a GLP-1, a Blood Test Worth a Second Look, and What Is in Your Glass
This week: how quickly weight returns after stopping semaglutide or tirzepatide, why a borderline normal haemoglobin may deserve a closer look, twe...
This week: how quickly weight returns after stopping semaglutide or tirzepatide, why a borderline normal haemoglobin may deserve a closer look, twe...
This week: a large trial finds statins cut heart attacks and strokes in healthy over seventies but do not prevent dementia or disability, a Scandin...
This week in plain English: the first wearable that tracks glucose and ketones together, the STAREE trial on statins for healthy over 70s, why miss...
The FDA has authorized Libre Duo, a wearable sensor designed to monitor glucose and ketones continuously for people with diabetes aged two years an...
This week, a nationwide Cyclospora outbreak tied to fast food lettuce, the first pill form of a powerful cholesterol drug, new data on activity lev...
The FDA warns TRUE METRIX meters can show one E-5 code for two very different problems. Don't stop testing — but arrange a backup meter when you ca...
The FDA posted an Omnipod correction — some Pods may under-deliver insulin. Not every Pod is affected. Check your lot numbers and keep a backup pla...
Two lots of Dexcom G7 sensors were stolen before destruction and resold. Check lot numbers 1725204004 and 1725069002. Here's what to do.
...
A Mass General Brigham study links fatty liver to a 69% higher relative risk of major heart events. Why your liver is talking to your heart.
...
The SURMOUNT-MAINTAIN trial answers what happens after you stop Mounjaro or Zepbound — and offers a lower-dose maintenance option that...